Betmiga prolonged-release tablets 25mg

Betmiga prolonged-release tablets 25mg

Category: Drug Info

Specifications
Details

Manufacturer
Avara Pharmaceutical Technologies, Inc.(UNITED STATES)

Registraction Number
MAL15015106ACRZ


Content:
  • Active Ingredient: Betamethasone 25mg
  • Excipients: Various inactive ingredients to stabilize the tablet
Indications:
  • Inflammatory Conditions: Used to reduce inflammation in conditions such as arthritis, allergies, and skin conditions.
  • Autoimmune Disorders: Used to manage symptoms of autoimmune diseases like lupus and multiple sclerosis.
  • Adrenal Insufficiency: Used as a replacement therapy in patients with adrenal insufficiency.
Instructions:
  1. Dosage and Administration: The dosage and administration should be determined by a healthcare provider based on the specific medical condition and patient needs. It is typically taken once daily, with or without food.
  2. Storage: Store at room temperature, away from moisture and heat.
  3. Handling: Take the tablet with a full glass of water. Do not crush or chew the tablet.
  4. Monitoring: Regular monitoring of blood pressure, blood sugar levels, and other relevant parameters as advised by the healthcare provider.

View more about Betmiga prolonged-release tablets 25mg on main site